Stay updated on Nivolumab in Hodgkin's Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in Hodgkin's Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the prior notices about government funding and operating status (v3.4.1) were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedSite-wide funding-delay notice was added at the top, and the release version updated to Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedAdded Show glossary feature and updated footer metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's Locations section was updated to include additional sites across the US, Canada, and the UK. The revision note shows version 3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedPublications section now states that items are automatically filled from PubMed and may not be about the study. A revision tag was updated to Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Hodgkin's Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.